QUATRAMER Trademark

Trademark Overview

On Friday, August 30, 2019, a trademark application was filed for QUATRAMER with the United States Patent and Trademark Office. The USPTO has given the QUATRAMER trademark a serial number of 88599949. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 6, 2023. This trademark is owned by Hillstream BioPharma, Inc.. The QUATRAMER trademark is filed in the Pharmaceutical Products category with the following description:

Nano particle technologies and nanoparticle technologies for cancer therapy and treatment, namely, drug delivery agents in the form of nanoparticles that provide controlled release of active ingredients for a wide variety of pharmaceuticals for the treatment of cancer
quatramer

General Information

Serial Number88599949
Word MarkQUATRAMER
Filing DateFriday, August 30, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Goods and ServicesNano particle technologies and nanoparticle technologies for cancer therapy and treatment, namely, drug delivery agents in the form of nanoparticles that provide controlled release of active ingredients for a wide variety of pharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHillstream BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChester, NJ 07930
Party NameHillstream BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChester, NJ 07930

Trademark Events

Event DateEvent Description
Monday, February 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 8, 2022SOU EXTENSION 5 GRANTED
Friday, June 24, 2022SOU EXTENSION 5 FILED
Friday, July 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 24, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 30, 2021SOU EXTENSION 4 GRANTED
Tuesday, November 30, 2021SOU EXTENSION 4 FILED
Tuesday, November 30, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, July 21, 2021ASSIGNED TO EXAMINER
Thursday, April 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 20, 2021SOU EXTENSION 3 GRANTED
Tuesday, April 20, 2021SOU EXTENSION 3 FILED
Tuesday, April 20, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 9, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2020SOU EXTENSION 2 GRANTED
Tuesday, October 20, 2020SOU EXTENSION 2 FILED
Tuesday, October 20, 2020SOU TEAS EXTENSION RECEIVED
Friday, May 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 6, 2020SOU EXTENSION 1 GRANTED
Wednesday, May 6, 2020SOU EXTENSION 1 FILED
Wednesday, May 6, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 30, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, September 25, 2019ASSIGNED TO LIE
Wednesday, September 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 25, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, September 25, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, September 23, 2019ASSIGNED TO EXAMINER
Thursday, September 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 3, 2019NEW APPLICATION ENTERED

Related Keywords

quatramer technologies treatment cancer release controlled provide active wide pharmaceuticals variety